BVF PARTNERS L P/IL Insider Trading $AVGN AVIGEN INC \DE
Get free email notifications about insider trading for BVF PARTNERS L P/IL.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of BVF PARTNERS L P/IL. BVF PARTNERS L P/IL is in KENT INTERNATIONAL HOLDINGS INC ($CRTQ) and 10% Owner in LIGAND PHARMACEUTICALS INC ($LGND) and 10% Owner in Capstone Therapeutics Corp. ($CAPS) and 10% Owner in REPLIGEN CORP ($RGEN) and 10% Owner in AVIGEN INC \DE ($AVGN) and 10% Owner in NEUROCRINE BIOSCIENCES INC ($NBIX) and 10% Owner in Astex Pharmaceuticals, Inc ($SUPG) and 10% Owner in ARQULE INC ($ARQL) and 10% Owner in NEUROBIOLOGICAL TECHNOLOGIES INC /CA/ ($NTII) and 10% Owner in RIGEL PHARMACEUTICALS INC ($RIGL) and 10% Owner in ARRAY BIOPHARMA INC ($ARRY) and 10% Owner in DYNAVAX TECHNOLOGIES CORP ($DVAX) and 10% Owner in EPIRUS Biopharmaceuticals, Inc. ($CRXX) and 10% Owner in CATALYST BIOSCIENCES, INC. ($CBIO) and 10% Owner in ICAGEN INC ($ICGN) and 10% Owner in ChemoCentryx, Inc. ($CCXI) and 10% Owner in Celera CORP ($CRA) and 10% Owner in ABBOTT BIOTHERAPEUTICS CORP ($FACT).
BVF PARTNERS L P/IL in AVIGEN INC \DE
Trading Symbol: AVGNIndustry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
Position of BVF PARTNERS L P/IL: 10% Owner
Holdings: 7,837,189 shares
Latest Transaction: Nov 20 2009
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of BVF PARTNERS L P/IL in AVIGEN INC \DE
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, FACT, ARQL, ARRY, SUPG, AVGN, CAPS, CBIO, CRA, CCXI, DVAX, CRXX, ICGN, CRTQ, LGND, NTII, NBIX, RGEN, RIGL
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Nov 20 2009 | AVGN | AVIGEN INC \DE | BVF PARTNERS L P/IL | 10% Owner | Sell | S | 1.50 | 626 | 939 | 7,837,189 | 7.8 M to 7.8 M (-0.01 %) |
Oct 23 2009 | AVGN | AVIGEN INC \DE | BVF PARTNERS L P/IL | 10% Owner | Sell | S | 1.50 | 277,000 | 415,500 | 7,837,815 | 8.1 M to 7.8 M (-3.41 %) |
Oct 23 2009 | AVGN | AVIGEN INC \DE | BVF PARTNERS L P/IL | 10% Owner | Sell | S | 1.50 | 80,000 | 120,000 | 8,114,815 | 8.2 M to 8.1 M (-0.98 %) |
Oct 23 2009 | AVGN | AVIGEN INC \DE | BVF PARTNERS L P/IL | 10% Owner | Sell | S | 1.50 | 115,200 | 172,800 | 8,194,815 | 8.3 M to 8.2 M (-1.39 %) |
Page: 1